Thomas DiRaimondo

Insider Reports History

Entity
Individual
Location
C/O Janux Therapeutics, Inc., 10955 Vista Sorrento Parkway, Suite 200, San Diego, CA
Signature
/s/ Maria Dobek, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Thomas DiRaimondo:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Janux Therapeutics, Inc. Chief Scientific Officer Common Stock 102K $596K $5.87 Jan 1, 2024 Direct
Janux Therapeutics, Inc. Chief Scientific Officer Stock Option (right to buy) 147K Jan 2, 2024 Direct

Insider Reports Filed by Thomas DiRaimondo

Symbol Company Period Transactions Value $ Form Type Date Filed Role
JANX Janux Therapeutics, Inc. Jan 2, 2024 1 $0 4 Jan 3, 2024 Chief Scientific Officer
JANX Janux Therapeutics, Inc. Jan 1, 2024 0 $0 3 Jan 3, 2024 Chief Scientific Officer